SCHEMBL2808061

SCHEMBL2808061

O=C(Nc1cc(NC(=O)Oc2ccc(Cl)cc2)cc(C(=O)O)c1)Oc1ccc(Cl)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 7/20 0.63
KMT2A Q03164 7/20 0.63
CYP1A2 P05177 1/20 0.49
WDR5 P61964 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.46
ALDH1A1 P00352 2/20 0.46
GAA P10253 1/20 0.46
HTT P42858 1/20 0.46
POLB P06746 4/20 0.45
TAAR1 Q96RJ0 1/20 0.44
KDM4E B2RXH2 1/20 0.44
MAPT P10636 1/20 0.44
RAB9A P51151 3/20 0.44
NPC1 O15118 2/20 0.44
SENP8 Q96LD8 1/20 0.44
SENP7 Q9BQF6 1/20 0.44
SENP6 Q9GZR1 1/20 0.44
LIPE Q05469 1/20 0.44
ALOX15 P16050 1/20 0.44
TSHR P16473 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2813628 0.85 CYP1A2 (0.65) MEN1KMT2ACYP1A2SMN1; SMN2ALDH1A1
SCHEMBL2811844 0.84 MEN1 (0.63) MEN1KMT2ACYP1A2SMN1; SMN2ALDH1A1
SCHEMBL2808736 0.82 CYP1A2 (0.65) MEN1KMT2ACYP1A2SMN1; SMN2ALDH1A1
SCHEMBL2812871 0.82 MAPT (0.55) MEN1KMT2ACYP1A2SMN1; SMN2ALDH1A1
SCHEMBL8650720 0.81 FAAH (0.52) CYP1A2SMN1; SMN2ALDH1A1GAAHTT
SCHEMBL8651102 0.81 SMN1; SMN2 (0.67) MEN1KMT2ACYP1A2SMN1; SMN2ALDH1A1
SCHEMBL8647344 0.81 KMT2A (0.58) MEN1KMT2ACYP1A2SMN1; SMN2ALDH1A1
SCHEMBL13132752 0.81 MEN1 (0.46) MEN1KMT2ACYP1A2SMN1; SMN2ALDH1A1
SCHEMBL8065643 0.80 ALDH1A1 (0.70) MEN1KMT2ACYP1A2SMN1; SMN2ALDH1A1
SCHEMBL13132593 0.78 CYP1A2 (0.46) MEN1KMT2ACYP1A2SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100240908-A1 ACETYLENE COMPOUND FUJIFILM CORPORATION (JP) 2010-09-23 US disclosed
EP-2202221-A1 ACETYLENE COMPOUND Fujifilm Corporation (JP) 2010-06-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240908-A1 ACETYLENE COMPOUND NAT1, KATNA1, KAT2B MEN1 579/4885KMT2A 730/4885CYP1A2 535/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.